US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 329.650
  • -1.800-0.54%
Trading Nov 29 09:51 ET
7.19BMarket Cap-13170P/E (TTM)

Madrigal Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Madrigal Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
34.41M
62.18M
+27.76M
Beat Est.
--
--
+80.67%
EPS
-6.92
-4.92
+2.00
Beat Est.
-29.63%
+7.87%
+28.93%
Analyst Rating
Strong Buy

Nov 29, 2024

Madrigal Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 97.442M--
--2024/Q4-- / 90.918M--
Oct 31, 20242024/Q362.175M / 34.414M--
Aug 7, 20242024/Q214.638M / 4.383M--
May 7, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 97.442M--
--2024/Q4-- / 90.918M--
Oct 31, 20242024/Q362.175M / 34.414M--
Aug 7, 20242024/Q214.638M / 4.383M--
May 7, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Madrigal Pharmaceuticals Earnings Reports

  • Madrigal Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 09:06 ET

  • Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

    Oct 31 07:10 ET

  • Madrigal Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 7 09:01 ET

  • Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates

    Aug 7 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 29, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      0.00%

    • Sell

      9.09%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data